China National Medicines (SHSE:600511) Volatility: 8.19% (As of Jul. 04, 2026)


SHSE:600511 China National Medicines Corp Ltd SHSE:600511
86 GF Score
Price ¥26.94
GF Value ¥32.74
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is China National Medicines Volatility?

China National Medicines SHSE:600511 +1.62% 86 Volatility is 8.19% as of Jul. 04, 2026. GuruFocus rates SHSE:600511 with a GF Score™ of 86/100 and a GF Value™ of ¥32.74 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-07-04), China National Medicines's Volatility is 8.19%.


China National Medicines  (SHSE:600511) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.


China National Medicines Volatility Related Terms


SHSE:600511 vs MCK, CAH, COR: Volatility Comparison

For the Medical Distribution subindustry, China National Medicines's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Medicines Volatility vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Medicines's Volatility distribution charts can be found below:

* The bar in red indicates where China National Medicines's Volatility falls into.


SHSE:600511
86GF Score
China National Medicines Corp Ltd SHSE:600511
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China National Medicines  (SHSE:600511) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * 12
= 1/(n-1) ∑(Ri - R')^2 * 12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 8.19% mean?
China National Medicines (SHSE:600511) has a Volatility of 8.19% as of Jul. 04, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on China National Medicines and its competitors.
Is China National Medicines' Volatility too high?
China National Medicines' current Volatility is 8.19%. Overall, China National Medicines has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does China National Medicines' Volatility compare to MCK and CAH?
China National Medicines' Volatility of 8.19% can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Medical Distribution company?
A good Volatility depends on the Medical Distribution industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on China National Medicines and its competitors. China National Medicines's current Volatility is 8.19%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China National Medicines stock overvalued right now?
Based on GuruFocus' analysis, China National Medicines (SHSE:600511) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥32.74, compared to a current price of ¥26.94 — trading 17.7% below its estimated fair value. The current Volatility is 8.19%. China National Medicines' overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For China National Medicines (SHSE:600511), the current Volatility is 8.19% as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China National Medicines (SHSE:600511) Overvalued in 2026?

Based on GuruFocus' analysis, China National Medicines stock appears to be undervalued. The current stock price of ¥26.94 is trading 17.7% below its estimated GF Value™ of ¥32.74. GuruFocus considers China National Medicines to be Modestly Undervalued.

Key valuation signals for SHSE:600511:

  • Volatility: 8.19%
  • GF Value™: ¥32.74 vs. price of ¥26.94 (17.7% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600511 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China National Medicines Business Description

Address No. 8, Xibinhe Road, Floor 6-9, West Tower, 7th Floor, Yongdingmen, Dongcheng District, Beijing, CHN, 100077
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The company conducts its operations through two primary segments. The Commercial segment is mainly engaged in the sale of pharmaceuticals. The Others segment focuses on pharmaceutical manufacturing and logistics operations.
86GF Score

Get the complete analysis for SHSE:600511

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥26.94
Price
¥32.74
GF Value